madopar hart hylki 100 mg og 25 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart hylki - 100 mg og 25 mg
madopar hart hylki 50 mg og 12,5 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart hylki - 50 mg og 12,5 mg
madopar tafla 125 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - tafla - 125 mg
madopar depot hart forðahylki 100 mg/25 mg
roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart forðahylki - 100 mg/25 mg
madopar quick lausnartafla 100 mg/25 mg
roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 100 mg/25 mg
madopar quick lausnartafla 50 mg/12,5 mg
roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 50 mg/12,5 mg
hydrocortison med terramycin og polymyxin b eyrna-/augndropar, dreifa
pfizer aps - polymyxinum b súlfat; oxytetracyclinum hýdróklóríð; hydrocortisonum acetat - eyrna-/augndropar, dreifa
nezeril nefdropar, lausn 0,25 mg/ml
perrigo sverige ab - oxymetazolinum hýdróklóríð - nefdropar, lausn - 0,25 mg/ml
nezeril nefdropar, lausn 0,5 mg/ml
perrigo sverige ab - oxymetazolinum hýdróklóríð - nefdropar, lausn - 0,5 mg/ml
ciflox (ciproxin-hydrocortison) eyrnadropar, dreifa 2 mg + 10 mg/ml
novartis healthcare a/s - ciprofloxacinum hýdróklóríð; hydrocortisonum inn - eyrnadropar, dreifa - 2 mg + 10 mg/ml